8-K filing — INOVIO PHARMACEUTICALS, INC. (INO)
Filed: 2026-10-06 AccNo: 0001193125-26-415555 Size: 151 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Inovio Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 EPS results.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Head and Neck Squamous Cell Carcinoma (HNSCC) - Market Insights, Epidemiology, and Market Forecast - 2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care
The HNSCC market is projected to grow from $850 million in 2025 to $2.56 billion by 2036 (10.5% CAGR), driven by HPV-targeted vaccines, checkpoint inhibitors, and biomarker-led patient selection. The US will remain the largest market at $2.082 billion. Key therapies include KEYTRUDA and OPDIVO, with emerging candidates like petosemtamab and amivantamab showing promise in clinical development.
Bet on 4 Top-Ranked Stocks With Rising P/E
The article explores how stocks with rising P/E ratios paired with accelerating earnings growth can deliver strong returns. Using specific screening criteria focused on earnings momentum and price performance, the analysis identifies four stocks: H World Group Limited (HTHT), Inovio Pharmaceuticals (INO), Nouveau Monde Graphite (NMG), and Cogent Communications (CCOI) as potential outperformers with consistent price gains and strong earnings surprises.
Bet on 5 Top-Ranked Stocks With Rising P/E
The article explores how rising P/E ratios, combined with accelerating earnings growth and sustained price momentum, can indicate strong investment opportunities. Five stocks meeting these criteria are highlighted: CuriosityStream (CURI), Inovio Pharmaceuticals (INO), GDS Holdings (GDS), Nouveau Monde Graphite (NMG), and Cogent Communications (CCOI). These companies demonstrate consistent price gains relative to the S&P 500 and positive earnings trends.